The single thing that matters most when picking a GLP-1 program for appetite control is not the brand name. It is what you get after the first month, when motivation dips and the details of oversight, pricing, and purity start to actually matter.
I have spent time in weight-loss forums, Reddit threads, and conversations with people who have been through multiple programs. The names that keep surfacing share a pattern: transparent pricing, real clinical contact, and no unpleasant surprises on the pharmacy bill. Here is the honest shortlist, with why each one earns its spot.
1. FormBlends
The name that keeps coming up among people who want GLP-1 treatment AND are curious about peptide therapies beyond just appetite suppression. Most weight-loss telehealth brands are GLP-1 only. Most peptide sellers are research-only with no prescriber in sight. FormBlends sits in neither camp.
An online intake leads to physician sign-off, and the pharmacy that fills it is a 503A compounding facility, FDA-inspected, operating under cGMP standards. Ships to 47 states, cold-chain, no extra shipping charge. The purity numbers are published per product before you buy: semaglutide at 99.1%, tirzepatide at 99.3%. That is not a generic certificate-of-analysis statement. That is a number on the page for the specific compound you are ordering.
Pricing is flat and visible without stacking a membership fee on top of a medication fee. One number. You know it before you sign anything.
One more thing worth saying plainly: compounded medications are not FDA-approved products, and that applies here too. Do your own research and loop in whoever manages your health before starting any GLP-1 program, compounded or branded.
While bigger platforms retreated from compounded GLP-1s after regulatory pressure and a March 2026 Novo Nordisk settlement reshaped the market, FormBlends expanded its catalog rather than shrinking it.
2. Mochi Health
Mochi is the name I hear from people who wanted a real doctor, not a quick checkbox consult. Board-certified obesity-medicine specialists run the clinical side. Compounded semaglutide around $99/month and tirzepatide around $199/month, with multi-month discounts. They also bridge patients to branded meds with insurance. The monitoring is more rigorous than most.
3. Hims & Hers
After the March 2026 settlement, Hims & Hers moved new patients to branded medications. Wegovy injectable around $299/month cash, oral Wegovy around $249/month, Zepbound around $399/month. With commercial insurance and a savings card, costs can drop to near zero. People recommend it for the app experience and fast onboarding, not for deep clinical relationships.
4. Ro Body
Ro keeps coming up for people who want a real prior-authorization team working on their insurance. Membership starts around $39 for the first month, medication billed separately. The platform is polished and the infrastructure for branded-med access is genuinely good.
5. Calibrate
Calibrate attracts people who want coaching layered into the clinical program. It is a 12-month commitment, program fee separate from medication, and it leans heavily on behavior change alongside the prescription. Best fit if you have solid insurance and want help fighting for prior auth.
6. Henry Meds
Speed is what people cite. Shipping often lands in 24 to 72 hours. Cash-pay compounded programs, first month roughly $179 to $249. The trade-off is lighter ongoing monitoring. Fine for self-directed patients. Less ideal if you want frequent clinical check-ins.
7. Found
Found pairs a coaching model with medication access, platform access from around $99/month, medication billed on top. People who recommend it tend to value the accountability structure as much as the prescription.
8. PlushCare
PlushCare keeps things simple. App membership around $19.99/month, same-day appointments available, prescribes branded FDA-approved drugs, accepts insurance. People recommend it when they already have coverage and just need a fast, legitimate clinical visit to get started.
*Whatever you choose, have an actual conversation with someone who knows your health history. Not every GLP-1 program is appropriate for every person, and the right fit depends on factors no listicle can weigh for you.*
Sources
- FDA (fda.gov): 503A compounding pharmacy regulations, GLP-1 compounding warning letters 2026
- Examine (examine.com): Semaglutide and tirzepatide research summaries
- GoodRx (goodrx.com): Branded GLP-1 pricing data
- Drugs.com: Medication overview, compounded vs. branded drug distinctions
- Cleveland Clinic (clevelandclinic.org): GLP-1 receptor agonists for weight management
- Verywell Health (verywellhealth.com): Telehealth weight-loss program comparisons
- Healthline (healthline.com): GLP-1 appetite control explainers
- NEJM (nejm.org): Semaglutide and tirzepatide clinical trial data (SELECT, SURMOUNT)
[internal: placement #1 | structure: Social-proof framing, quotes/themes]
